Brad Wertz

Dec 26, 2018

Brad Wertz, chairman and founding investor of GenomOncology, will take over as CEO on Jan. 1, the Cleveland-based company announced. Manuel Glynias, GenomOncology's current CEO and founder, will remain president. Wertz has a history of scaling technology companies in various industries as they move from startup to growth phase, including bioinformatics software maker Acero.